J. Whitaker
Chief Tech/Sci/R&D Officer bij OMEROS CORPORATION
Profiel
J.
Steven Whitaker is currently the Vice President-Clinical Development at Omeros Corp.
He previously worked as the Divisional Vice President at ICOS Corp from 1994 to 2007 and as the Chief Medical Officer & VP-Clinical Development at Allon Therapeutics, Inc. from 2008 to 2010.
Whitaker holds a graduate degree from the University of Washington, an undergraduate degree from Butler University, and a doctorate degree from The Indiana University School of Medicine.
Actieve functies van J. Whitaker
| Bedrijven | Functie | Begin |
|---|---|---|
| OMEROS CORPORATION | Chief Tech/Sci/R&D Officer | 01-11-2019 |
Eerdere bekende functies van J. Whitaker
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLON THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01-03-2010 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01-05-2007 |
Opleiding van J. Whitaker
| University of Washington | Graduate Degree |
| Butler University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| ALLON THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
